Provided by Tiger Trade Technology Pte. Ltd.

Esperion Therapeutics

3.66
+0.485015.30%
Volume:13.65M
Turnover:49.14M
Market Cap:873.78M
PE:-6.82
High:3.77
Open:3.28
Low:3.28
Close:3.17
52wk High:3.94
52wk Low:0.6925
Shares:239.06M
Float Shares:237.00M
Volume Ratio:3.40
T/O Rate:5.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5358
EPS(LYR):-0.2764
ROE:97.76%
ROA:-5.42%
PB:-1.94
PE(LYR):-13.22

Loading ...

Esperion Announces New Data From Clear Outcomes Highlighting Value of Nexletol® (Bempedoic Acid) in Oral and Poster Presentations at the Aha Scientific Sessions 2025

THOMSON REUTERS
·
Nov 10

Esperion Announces New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) in Oral and Poster Presentations at the AHA Scientific Sessions 2025

GlobeNewswire
·
Nov 10

Esperion Therapeutics Grants 77,650 RSUs to New Employees Under Inducement Plan

Reuters
·
Nov 07

Esperion Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Nov 07

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 07

Esperion Q3 revenue up 69% on prescription volumes

Reuters
·
Nov 06

Stock Track | Esperion Therapeutics Plunges 6.12% Pre-market on Disappointing Q3 Earnings

Stock Track
·
Nov 06

Stock Track | Esperion Therapeutics Plunges 6.12% Pre-Market on Disappointing Q3 Earnings

Stock Track
·
Nov 06

Esperion Therapeutics Q3 EPS $(0.16) Misses $(0.08) Estimate, Sales $87.309M Beat $77.803M Estimate

Benzinga
·
Nov 06

Esperion Reiterates 2025 Operating Expense Guidance at $215–$235 Million

Reuters
·
Nov 06

BRIEF-Esperion Therapeutics Q3 Product Sales USD 40.659 Million

Reuters
·
Nov 06

Esperion Therapeutics Inc Reiterates Its Expectation for Full Year 2025 Operating Expenses to Be in the Range of $215 Million to $235 Million

THOMSON REUTERS
·
Nov 06

Esperion Therapeutics Expects to Achieve Sustainable Profitability Beginning in the First Quarter of 2026

THOMSON REUTERS
·
Nov 06

Esperion Therapeutics Appoints John Harlow as Chief Commercial Officer

Reuters
·
Nov 04

Press Release: Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer

Dow Jones
·
Nov 04

Esperion to Participate in Jefferies Global Healthcare Conference - London

GlobeNewswire
·
Nov 03

GS1 Hong Kong Equips Local Businesses to Turn EU's Digital Product Passport Mandate into a Competitive Edge

prnewswire
·
Oct 31

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.

GlobeNewswire
·
Oct 28

Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025

GlobeNewswire
·
Oct 27

Esperion to Report Third Quarter 2025 Financial Results on November 6

GlobeNewswire
·
Oct 23